INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer
NCT04781725
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
INT230-6
OTHER:
Saline injection
Sponsor
Ottawa Hospital Research Institute
Collaborators
[object Object]
[object Object]